{"pmid":32476189,"title":"SARS-CoV-2 pandemic and Vitamin D deficiency - a double trouble.","text":["SARS-CoV-2 pandemic and Vitamin D deficiency - a double trouble.","The current SARS-CoV-2 pandemic has mandated significant isolation measures. Streets in affected countries are mostly empty, and many individuals spend several consecutive days at home to reduce the risk of infection. While determinant for pandemic control, home reclusion may have a significant toll on the health of individuals.","Photodermatol Photoimmunol Photomed","Alpalhao, Miguel","Filipe, Paulo","32476189"],"abstract":["The current SARS-CoV-2 pandemic has mandated significant isolation measures. Streets in affected countries are mostly empty, and many individuals spend several consecutive days at home to reduce the risk of infection. While determinant for pandemic control, home reclusion may have a significant toll on the health of individuals."],"journal":"Photodermatol Photoimmunol Photomed","authors":["Alpalhao, Miguel","Filipe, Paulo"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32476189","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/phpp.12579","keywords":["sars-cov-2","isolation","pandemic","vitamin d"],"locations":["Vitamin"],"topics":["Prevention"],"weight":1,"_version_":1668437835013685248,"score":9.490897,"similar":[{"pmid":32403202,"title":"The Power of 'Pause'-A Time for Medical Students to Reflect and Mobilize.","text":["The Power of 'Pause'-A Time for Medical Students to Reflect and Mobilize.","The COVID-19 pandemic has forced the entire world to stop. Silence occupies side streets while emptiness cleanses our oceans and skies. For those who have the privilege of staying home, the world feels frozen. Everything and everyone are paused, with the exception of healthcare and other essential workers. On the front lines, physicians, nurses, respiratory therapists and other healthcare workers are overwhelmed. Emergency rooms are inundated, and intensive care units are besieged with COVID-19 patients.","Med Educ","Spach, Natalie C","32403202"],"abstract":["The COVID-19 pandemic has forced the entire world to stop. Silence occupies side streets while emptiness cleanses our oceans and skies. For those who have the privilege of staying home, the world feels frozen. Everything and everyone are paused, with the exception of healthcare and other essential workers. On the front lines, physicians, nurses, respiratory therapists and other healthcare workers are overwhelmed. Emergency rooms are inundated, and intensive care units are besieged with COVID-19 patients."],"journal":"Med Educ","authors":["Spach, Natalie C"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32403202","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1111/medu.14216","topics":["Prevention"],"weight":1,"_version_":1666714494849515521,"score":123.117714},{"pmid":32503801,"title":"Does vitamin D deficiency increase the severity of COVID-19?","text":["Does vitamin D deficiency increase the severity of COVID-19?","The severity of coronavirus 2019 infection (COVID-19) is determined by the presence of pneumonia, severe acute respiratory distress syndrome (SARS-CoV-2), myocarditis, microvascular thrombosis and/or cytokine storms, all of which involve underlying inflammation. A principal defence against uncontrolled inflammation, and against viral infection in general, is provided by T regulatory lymphocytes (Tregs). Treg levels have been reported to be low in many COVID-19 patients and can be increased by vitamin D supplementation. Low vitamin D levels have been associated with an increase in inflammatory cytokines and a significantly increased risk of pneumonia and viral upper respiratory tract infections. Vitamin D deficiency is associated with an increase in thrombotic episodes, which are frequently observed in COVID-19. Vitamin D deficiency has been found to occur more frequently in patients with obesity and diabetes. These conditions are reported to carry a higher mortality in COVID-19. If vitamin D does in fact reduce the severity of COVID-19 in regard to pneumonia/ARDS, inflammation, inflammatory cytokines and thrombosis, it is our opinion that supplements would offer a relatively easy option to decrease the impact of the pandemic.","Clin Med (Lond)","Weir, E Kenneth","Thenappan, Thenappan","Bhargava, Maneesh","Chen, Yingjie","32503801"],"abstract":["The severity of coronavirus 2019 infection (COVID-19) is determined by the presence of pneumonia, severe acute respiratory distress syndrome (SARS-CoV-2), myocarditis, microvascular thrombosis and/or cytokine storms, all of which involve underlying inflammation. A principal defence against uncontrolled inflammation, and against viral infection in general, is provided by T regulatory lymphocytes (Tregs). Treg levels have been reported to be low in many COVID-19 patients and can be increased by vitamin D supplementation. Low vitamin D levels have been associated with an increase in inflammatory cytokines and a significantly increased risk of pneumonia and viral upper respiratory tract infections. Vitamin D deficiency is associated with an increase in thrombotic episodes, which are frequently observed in COVID-19. Vitamin D deficiency has been found to occur more frequently in patients with obesity and diabetes. These conditions are reported to carry a higher mortality in COVID-19. If vitamin D does in fact reduce the severity of COVID-19 in regard to pneumonia/ARDS, inflammation, inflammatory cytokines and thrombosis, it is our opinion that supplements would offer a relatively easy option to decrease the impact of the pandemic."],"journal":"Clin Med (Lond)","authors":["Weir, E Kenneth","Thenappan, Thenappan","Bhargava, Maneesh","Chen, Yingjie"],"date":"2020-06-07T11:00:00Z","year":2020,"_id":"32503801","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.7861/clinmed.2020-0301","keywords":["covid 19","treg","vitamin d","coronavirus","inflammation"],"e_drugs":["Vitamin D"],"topics":["Treatment"],"weight":1,"_version_":1668892488253833216,"score":120.11927},{"pmid":32216248,"title":"[Prevention and control of SARS-CoV-2 (Covid-19) coronavirus infection in hemodialysis units].","text":["[Prevention and control of SARS-CoV-2 (Covid-19) coronavirus infection in hemodialysis units].","The SARS-CoV-2 pandemic is of hich risk for patients on chronic hemodialysis due to their immunosuppressed state, advanced age, and the coexistence of significant comorbidities, in particular cardiovascular disease, diabetes mellitus, and others. Additionally, they constitute a closed conglomerate since they come to treatment regularly, spending hours in the treatment places, exposed to a possible acquisition of the infection. Finally, going to their treatment regularly prevents them from remaining in home isolation and with potential exposure. These recommendations summarize the interventions proposed by three international organizations and add some suggested by national experts, with the aim to early identify the patients and health personnel at risk and reducing the risk of infection.","Salud Publica Mex","Vega-Vega, Olynka","Arvizu-Hernandez, Mauricio","Dominguez-Cherit, Jose Guillermo","Sierra-Madero, Juan","Correa-Rotter, Ricardo","32216248"],"abstract":["The SARS-CoV-2 pandemic is of hich risk for patients on chronic hemodialysis due to their immunosuppressed state, advanced age, and the coexistence of significant comorbidities, in particular cardiovascular disease, diabetes mellitus, and others. Additionally, they constitute a closed conglomerate since they come to treatment regularly, spending hours in the treatment places, exposed to a possible acquisition of the infection. Finally, going to their treatment regularly prevents them from remaining in home isolation and with potential exposure. These recommendations summarize the interventions proposed by three international organizations and add some suggested by national experts, with the aim to early identify the patients and health personnel at risk and reducing the risk of infection."],"journal":"Salud Publica Mex","authors":["Vega-Vega, Olynka","Arvizu-Hernandez, Mauricio","Dominguez-Cherit, Jose Guillermo","Sierra-Madero, Juan","Correa-Rotter, Ricardo"],"date":"2020-03-28T11:00:00Z","year":2020,"_id":"32216248","source":"PubMed","week":"202013|Mar 23 - Mar 29","doi":"10.21149/11330","keywords":["coronavirus infection","hemodialysis","pandemic","primary prevention","recommendations"],"topics":["Prevention"],"weight":1,"_version_":1666138492338438146,"score":104.63362},{"pmid":32430111,"title":"Achieving Safe, Effective, and Compassionate Quarantine or Isolation of Older Adults With Dementia in Nursing Homes.","text":["Achieving Safe, Effective, and Compassionate Quarantine or Isolation of Older Adults With Dementia in Nursing Homes.","Nursing homes are facing the rapid spread of COVID-19 among residents and staff and are at the centre of the public health emergency due to the COVID-19 pandemic. As policy changes and interventions designed to support nursing homes are put into place, there are barriers to implementing a fundamental, highly effective element of infection control, namely the isolation of suspected or confirmed cases. Many nursing home residents have dementia, associated with impairments in memory, language, insight, and judgment that impact their ability to understand and appreciate the necessity of isolation and to voluntarily comply with isolation procedures. While there is a clear ethical and legal basis for the involuntary confinement of people with dementia, the potential for unintended harm with these interventions is high, and there is little guidance for nursing homes on how to isolate safely, while maintaining the human dignity and personhood of the individual with dementia. In this commentary, we discuss strategies for effective, safe, and compassionate isolation care planning, and present a case vignette of a person with dementia who is placed in quarantine on a dementia unit.","Am J Geriatr Psychiatry","Iaboni, Andrea","Cockburn, Amy","Marcil, Meghan","Rodrigues, Kevin","Marshall, Cecelia","Garcia, Mary Anne","Quirt, Hannah","Reynolds, Katelyn B","Keren, Ron","Flint, Alastair J","32430111"],"abstract":["Nursing homes are facing the rapid spread of COVID-19 among residents and staff and are at the centre of the public health emergency due to the COVID-19 pandemic. As policy changes and interventions designed to support nursing homes are put into place, there are barriers to implementing a fundamental, highly effective element of infection control, namely the isolation of suspected or confirmed cases. Many nursing home residents have dementia, associated with impairments in memory, language, insight, and judgment that impact their ability to understand and appreciate the necessity of isolation and to voluntarily comply with isolation procedures. While there is a clear ethical and legal basis for the involuntary confinement of people with dementia, the potential for unintended harm with these interventions is high, and there is little guidance for nursing homes on how to isolate safely, while maintaining the human dignity and personhood of the individual with dementia. In this commentary, we discuss strategies for effective, safe, and compassionate isolation care planning, and present a case vignette of a person with dementia who is placed in quarantine on a dementia unit."],"journal":"Am J Geriatr Psychiatry","authors":["Iaboni, Andrea","Cockburn, Amy","Marcil, Meghan","Rodrigues, Kevin","Marshall, Cecelia","Garcia, Mary Anne","Quirt, Hannah","Reynolds, Katelyn B","Keren, Ron","Flint, Alastair J"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32430111","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.jagp.2020.04.025","keywords":["covid-19","dementia","infection control","isolation","nursing homes"],"topics":["Prevention"],"weight":1,"_version_":1667342288383115266,"score":95.8521},{"pmid":32397275,"title":"Potential Role of Vitamin D in the Elderly to Resist COVID-19 and to Slow Progression of Parkinson's Disease.","text":["Potential Role of Vitamin D in the Elderly to Resist COVID-19 and to Slow Progression of Parkinson's Disease.","While we are still learning more about COVID-19, caused by the novel SARS-CoV-2 virus, finding alternative and already available methods to reduce the risk and severity of the disease is paramount. One such option is vitamin D, in the form of vitamin D3 (cholecalciferol) supplementation, due to its potential antiviral properties. It has become apparent that older individuals have a greater risk of developing severe COVID-19, and compared to younger adults, the elderly have lower levels of vitamin D due to a variety of biological and behavioral factors. Older adults are also more likely to be diagnosed with Parkinson's disease (PD), with advanced age being the single greatest risk factor. In addition to its immune-system-modulating effects, it has been suggested that vitamin D supplementation plays a role in slowing PD progression and improving PD-related quality of life. We completed a review of the literature to determine the relationship between vitamin D, PD, and COVID-19. We concluded that the daily supplementation of 2000-5000 IU/day of vitamin D3 in older adults with PD has the potential to slow the progression of PD while also potentially offering additional protection against COVID-19.","Brain Sci","Hribar, Casey A","Cobbold, Peter H","Church, Frank C","32397275"],"abstract":["While we are still learning more about COVID-19, caused by the novel SARS-CoV-2 virus, finding alternative and already available methods to reduce the risk and severity of the disease is paramount. One such option is vitamin D, in the form of vitamin D3 (cholecalciferol) supplementation, due to its potential antiviral properties. It has become apparent that older individuals have a greater risk of developing severe COVID-19, and compared to younger adults, the elderly have lower levels of vitamin D due to a variety of biological and behavioral factors. Older adults are also more likely to be diagnosed with Parkinson's disease (PD), with advanced age being the single greatest risk factor. In addition to its immune-system-modulating effects, it has been suggested that vitamin D supplementation plays a role in slowing PD progression and improving PD-related quality of life. We completed a review of the literature to determine the relationship between vitamin D, PD, and COVID-19. We concluded that the daily supplementation of 2000-5000 IU/day of vitamin D3 in older adults with PD has the potential to slow the progression of PD while also potentially offering additional protection against COVID-19."],"journal":"Brain Sci","authors":["Hribar, Casey A","Cobbold, Peter H","Church, Frank C"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32397275","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.3390/brainsci10050284","keywords":["covid-19","parkinson's disease","sars-cov-2","antiviral","cholecalciferol","elderly","neurodegeneration","therapeutics","vitamin d"],"e_drugs":["Vitamin D","Cholecalciferol"],"topics":["Treatment"],"weight":1,"_version_":1666714494926061568,"score":94.31362}]}